LFE life therapeutics limited

life therapeutics to supply anti anthrax plasma

  1. fluffynymph
    56,989 Posts.
    lightbulb Created with Sketch. 293
    clock Created with Sketch.
    06/09/06
    12:11
    Post #: 1778100
    Sydney - Wednesday - September 6: (RWE Aust Business News) - Life
    Therapeutics (ASX:LFE) will supply Cangene Corp with anti-anthrax plasma
    to produce a hyperimmune product for the US Department of Health and
    Human Services.
    This is a $US143m project for Cangene under Project BioShield to
    produce 10,000 doses of anthrax immune globulin for treating inhalational
    anthrax.
    LFE Price at posting: 0.0¢ Sentiment: Buy Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS High-grade silver intercepts confirmed at Kempfield Project
right-arrow Created with Sketch.
NEWS ANSTO continuous piloting confirms exceptional rare earth recoveries
right-arrow Created with Sketch.
NEWS First assay results returned from ongoing drilling at Gold Duke Project
right-arrow Created with Sketch.
AII Becoming the largest conflict-free tungsten supplier in the world
right-arrow Created with Sketch.
NEWS The biggest ASX director trades from the last week
right-arrow Created with Sketch.
NEWS Explore the latest ASX Market News
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.